Literature DB >> 12051758

Subgenomic replicon derived from a cell line infected with the hepatitis C virus.

Hiroe Kishine1, Kazuo Sugiyama, Makoto Hijikata, Nobuyuki Kato, Hitoshi Takahashi, Takeshi Noshi, Yasunori Nio, Masahiro Hosaka, Yusuke Miyanari, Kunitada Shimotohno.   

Abstract

Recently, cell culture systems have been established, where a hepatitis C virus (HCV) subgenomic replicon was efficiently replicated and maintained for a long period. To see whether a HCV sequence derived from HCV-infected cultured cell sequence can be used for the construction of a functional replicon, a HCV subgenomic RNA carrying a neomycin-resistant gene was constructed using the HCV genome RNA obtained from cultured cells infected with HCV. After transfection, G418-resistant Huh-7 cells were selected and subcloned. Finally, the production of HCV proteins and de novo synthesis of subgenomic RNA were confirmed in the selected cell clone, indicating that this subgenomic RNA replicated in cultured cells and functioned as a replicon. These results suggest that the HCV genome obtained from an in vitro HCV infection system with cultured cells can be used to develop a subgenomic replicon system with diverse HCV sequences. (c) 2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12051758     DOI: 10.1016/S0006-291X(02)00342-X

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  20 in total

Review 1.  RNAi therapeutics: principles, prospects and challenges.

Authors:  Lars Aagaard; John J Rossi
Journal:  Adv Drug Deliv Rev       Date:  2007-03-16       Impact factor: 15.470

2.  Bioconversion of FR901459, a novel derivative of cyclosporin A, by Lentzea sp. 7887.

Authors:  Satoshi Sasamura; Motoo Kobayashi; Hideyuki Muramatsu; Seiji Yoshimura; Takayoshi Kinoshita; Hidenori Ohki; Kazuki Okada; Yoko Deai; Yukiko Yamagishi; Michizane Hashimoto
Journal:  J Antibiot (Tokyo)       Date:  2015-03-18       Impact factor: 2.649

3.  Novel robust hepatitis C virus mouse efficacy model.

Authors:  Qing Zhu; Yoko Oei; Dirk B Mendel; Evelyn N Garrett; Montesa B Patawaran; Paul W Hollenbach; Sharon L Aukerman; Amy J Weiner
Journal:  Antimicrob Agents Chemother       Date:  2006-10       Impact factor: 5.191

4.  Diverse effects of cyclosporine on hepatitis C virus strain replication.

Authors:  Naoto Ishii; Koichi Watashi; Takayuki Hishiki; Kaku Goto; Daisuke Inoue; Makoto Hijikata; Takaji Wakita; Nobuyuki Kato; Kunitada Shimotohno
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

5.  Replication studies using genotype 1a subgenomic hepatitis C virus replicons.

Authors:  Baohua Gu; Adam T Gates; Olaf Isken; Sven-Erik Behrens; Robert T Sarisky
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

Review 6.  New hepatitis C virus drug discovery strategies and model systems.

Authors:  Snawar Hussain; Naina Barretto; Susan L Uprichard
Journal:  Expert Opin Drug Discov       Date:  2012-08-04       Impact factor: 6.098

7.  Interference of hepatitis C virus RNA replication by short interfering RNAs.

Authors:  Sharookh B Kapadia; Amy Brideau-Andersen; Francis V Chisari
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-03       Impact factor: 11.205

8.  Genetic analysis of hepatitis C virus with defective genome and its infectivity in vitro.

Authors:  Kazuo Sugiyama; Kenji Suzuki; Takahide Nakazawa; Kenji Funami; Takayuki Hishiki; Kazuya Ogawa; Satoru Saito; Kumiko W Shimotohno; Takeshi Suzuki; Yuko Shimizu; Reiri Tobita; Makoto Hijikata; Hiroshi Takaku; Kunitada Shimotohno
Journal:  J Virol       Date:  2009-04-15       Impact factor: 5.103

9.  Heat-shock protein 90 is essential for stabilization of the hepatitis C virus nonstructural protein NS3.

Authors:  Saneyuki Ujino; Saori Yamaguchi; Kunitada Shimotohno; Hiroshi Takaku
Journal:  J Biol Chem       Date:  2009-01-16       Impact factor: 5.157

10.  Phosphorylation of hepatitis C virus nonstructural protein 5A modulates its protein interactions and viral RNA replication.

Authors:  Matthew J Evans; Charles M Rice; Stephen P Goff
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-23       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.